🇺🇸 FDA
Patent

US 10039762

Inhibitors of influenza viruses replication

granted A61KA61K31/506A61K31/5377

Quick answer

US patent 10039762 (Inhibitors of influenza viruses replication) held by Vertex Pharmaceuticals Incorporated expires Mon Aug 02 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Aug 07 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 02 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K31/506, A61K31/5377, A61K31/55, A61K31/553